Anti-gp40 x Anti-TFRC Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-gp40 and anti-TFRC parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind two tumor antigens simultaneously. It is designed for the research of Colon cancer; Ovarian cancer therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY